Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$44,360
-$14,835,780 QoQ
Shares Held
4,436
-99.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#264
of 316 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $406,344,526 across 19 Drug Manufacturers - Specialty & Generic names. BCRX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,556,307 | $111,836,221 | |
| 2 | VTRS |
Viatris Inc
|
5,928,142 | $94,138,894 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
155,398 | $84,199,298 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
419,770 | $70,748,035 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
277,282 | $10,037,608 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
186,134 | $8,798,554 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
81,486 | $6,745,411 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
212,814 | $5,399,091 |
All Filings in BCRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,360 | 4,436 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,880,140 | 1,563,040 | Shares | Sole | 2026-06-18 | |
| 2024-06-30 | $16,370 | 2,649 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $37,114 | 7,306 | Shares | Sole | 2024-05-10 | |
| 2021-03-31 | $62,820 | 6,177 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $118,790 | 15,945 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $84,290 | 24,503 | Shares | Sole | 2020-10-19 | |
| No filing history on record for this holder in this stock. | ||||||